✦ LIBER ✦

Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials

✍ Scribed by Alice B. Kornblith; Margaret Kemeny; Bercedis L. Peterson; Judith Wheeler; Jeffrey Crawford; Nancy Bartlett; Gini Fleming; Stephen Graziano; Hyman Muss; Harvey Jay Cohen; Cancer; Leukemia Group B

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 80 KB
Volume: 95
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.10792

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Barriers to the participation of African

Barriers to the participation of African-American patients with cancer in clinical trials : A pilot study

✍ Anjali S. Advani; Benjamin Atkeson; Carrie L. Brown; Bercedis L. Peterson; Laura 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Background: African-american patients have been under-represented in oncology clinical trials. better understanding barriers to african-american participation may help increase the accrual of african-american patients onto clinical trials. ## Methods: Two hundred eighteen patients with maligna

A concept for the clinical implementatio

A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance

✍ Thorsten Kuehn; Andreas Bembenek; Thomas Decker; Dieter Ludwig Munz; Marie-Luise 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

## Abstract The development of standardized and reproducible clinical pathways is an important precondition for quality assurance in medicine, especially if a new method has not yet been ultimately validated. Sentinel lymph node biopsy (SLNB) is a widely accepted new surgical procedure in the treat

Prospective randomized clinical trial to

Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma

✍ Adam Taube; Göran Lundell 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

outcome of 87 patients with gallbladder carcinoma (GBC) who underwent surgery. The authors concluded that surgical resection provides significantly better survival than a bypass procedure or exploratory laparotomy alone. Because radical tumor resection may significantly improve survival as compared

Prospective randomized clinical trial to

Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma

✍ Chandrasekhar Bal; Ajit K. Padhy; Suman Jana; Gauri S. Pant; Amar K. Basu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

## BACKGROUND. Radioiodine has been used for more than a half-century to ablate thyroid remnants following thyroid surgery, but a single optimal dose has not been established. We designed a prospective randomized trial to determine the optimal dose of 13'1 for remnant ablation. METHODS. Using a si

Incidence of anaphylactoid reactions to

Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis : Results of a surgical prospective clinical practice protocol

✍ Chandrajit P. Raut; Kelly K. Hunt; Jeri S. Akins; M. Denise Daley; Merrick I. Ro 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

A Phase I dose escalation trial of conti

A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma

✍ Todd M. Zimmerman; David L. Grinblatt; Rebecca Malloy; Stephanie F. Williams 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## BACKGROUND. Paclitaxel, an effective chemotherapeutic agent in the management of breast carcinoma, may have activity in women whose disease has recurred after high dose chemotherapy. With this is mind the authors explored the addition of a 120-hour continuous infusion of paclitaxel to a previou